PHARMADAN A/S: Financial statements 2014
CVR: 26524938
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
PHARMADAN A/S (CVR 26524938) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 2,910,552 and a net result of DKK -847,642 compared with DKK -3,787,696 the year before. Equity in the 2014 report amounted to DKK 379,735. The solvency ratio was 4.6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,910,552
- Profit/Loss
- DKK -847,642
- Equity
- DKK 379,735
- Total Assets
- DKK 8,273,622
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 2.9M | -848K | 380K | 3 |
| 2013 | - | -751K | -3.8M | -5.8M | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout PHARMADAN A/S
PHARMADAN A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 2002. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Peter Rørvig. The board consists of Helle Rørvig, Niels Ulrik Heine and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,382,654 and a net result of DKK -5,426,641 compared with DKK -5,113,611 the year before. Equity in the 2025 report amounted to DKK -18,955,125.